Health Catalyst HCAT Available-for-Sale Debt Securities - Amortized Cost
Available-for-Sale Debt Securities - Amortized Cost at other companies
Other financials
Where this comes from
Reported directly by Health Catalyst in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss.
The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Health Catalyst's available-for-sale debt securities - amortized cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Health Catalyst's available-for-sale debt securities - amortized cost?
- Health Catalyst (HCAT) reported available-for-sale debt securities - amortized cost of $100.14M in Q1 2026.
- What is the long-term trend for Health Catalyst's available-for-sale debt securities - amortized cost?
- Over 5 years (2020 to 2025), Health Catalyst's available-for-sale debt securities - amortized cost has grown at a -19.0% compound annual growth rate (CAGR), from $258.29M to $89.93M.
- What does available-for-sale debt securities - amortized cost mean?
- This is the cost basis of debt securities classified as available-for-sale, adjusted for amortization of premiums or discounts. It represents the value of the investment portfolio before accounting for current market price fluctuations. This provides a baseline for evaluating the performance of the company's liquid investment strategy.